Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full
Aurelia Zimmerli1, Matteo Monti1,2, Craig Fenwick3
1Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Frontiers in Immunology
|May 10, 2021
Summary
Convalescent plasma rapidly reduced inflammation and cleared SARS-CoV-2 in an immunosuppressed COVID-19 patient. This suggests potential for broader use in immunocompromised individuals receiving B-cell depleting therapies.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Concerns exist regarding SARS-CoV-2 effects on immunocompromised patients, especially those on B-cell depleting agents.
- Convalescent plasma is a potential therapy for these vulnerable patients.
- Understanding convalescent plasma mechanisms is key for optimizing its use.
Observation:
- A deeply immunosuppressed patient with chronic lymphoid leukemia, treated with rituximab and chemotherapy, developed COVID-19.
- The patient's severe T and B cell lymphopenia provided a unique model to assess convalescent plasma efficacy.
- Clinical, biological, radiological, and virological parameters were monitored throughout treatment.
Findings:
- The first convalescent plasma transfusion rapidly improved pneumonia, inflammation, and blood counts, suggesting immunomodulatory effects.
- Subsequent transfusions led to increased anti-SARS-CoV-2 neutralizing antibodies.
- This was associated with progressive viral clearance, complete viral eradication, and full clinical recovery.
Implications:
- Convalescent plasma demonstrated a stepwise therapeutic effect: initial anti-inflammatory activity followed by viral clearance.
- These findings support the expanded use of convalescent plasma in immunosuppressed COVID-19 patients.
- The results may inform future strategies using monoclonal antibodies for this patient population.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
158
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
158
Acute Pancreatitis II: Clinical Manifestations and Management
376
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
376
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
90
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
90
Nephrotic Syndrome I : Introduction
231
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
231
Acute Kidney Injury I: Introduction
231
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
231
Nephrotic Syndrome II : Assessment and Medical Management
52
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
52


